Form 4: Dyne Therapeutics CSO Oxana Beskrovnaya Sells Shares to Cover Tax Obligations

Oxana Beskrovnaya, Chief Scientific Officer of Dyne Therapeutics, sold 2,339 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Oxana Beskrovnaya, the Chief Scientific Officer of Dyne Therapeutics, sold 2,339 shares of the company's common stock on September 18, 2024.
• The sale was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs) granted on September 17, 2020.
• The shares were sold at a weighted average price of $34.55, with individual transactions ranging from $34.35 to $34.70.
• Following the transaction, Beskrovnaya directly owns 140,375 shares, which includes 110,062 unvested RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context.

Key Dates